A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Nature Communications (2022) - Comments
pubmed: 35046397  doi: 10.1038/s41467-022-28064-7  issn: 2041-1723 

Yogiraj Ray, Shekhar Ranjan Paul, Purbita Bandopadhyay, Ranit D’Rozario, Jafar Sarif, Deblina Raychaudhuri, Debaleena Bhowmik, Abhishake Lahiri, Janani Srinivasa Vasudevan, Ranjeet Maurya, Akshay Kanakan, Sachin Sharma, Manish Kumar, Praveen Singh, Rammohan Roy, Kausik Chaudhury, Rajsekhar Maiti, Saugata Bagchi, Ayan Maiti, Md. Masoom Perwez